EGFR and lung adenocarcinoma: Tang et al. showed that both ATM and EGFR inhibitors promote radiosensitivity through the HR pathway, not via the NHEJ pathway, in lung adenocarcinoma, cervical cancer, GBM, and colorectal carcinoma [32].